Hepatitis

This section will cover the major viral pathogens causing hepatitis, focusing on Hepatitis A Virus (HAV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV). We will discuss their etiology, epidemiology, transmission, disease states, and key differences

Viral Hepatitis

  • Definition: Hepatitis is inflammation of the liver, most commonly caused by viral infections. Other causes include alcohol, drugs, autoimmune diseases, and metabolic disorders. Viral hepatitis can be acute (short-term) or chronic (long-term)

Hepatitis A Virus (HAV)

  • Etiology
    • Classification: A member of the Picornaviridae family
    • Non-Enveloped RNA Virus: HAV is a single-stranded RNA virus
    • One Serotype: There is only one serotype of HAV
  • Epidemiology
    • Global Distribution: Found worldwide, but more common in areas with poor sanitation and hygiene
    • Seasonality: Can occur year-round, but outbreaks are more common in the fall and winter
    • Age Groups: Can affect all age groups, but children are often asymptomatic
  • Transmission
    • Fecal-Oral Route: Primarily spread through the fecal-oral route via contaminated food, water, or surfaces
    • Close Contact: Can also be spread through close personal contact with an infected individual
    • Outbreaks: Common in settings with poor sanitation, such as restaurants, daycare centers, and schools
  • Disease States
    • Acute Hepatitis: Characterized by fever, fatigue, nausea, vomiting, abdominal pain, jaundice (yellowing of the skin and eyes), dark urine, and pale stools
    • Symptoms: Typically begin 2-6 weeks after exposure and last for several weeks to months
    • Chronic Infection: HAV does not cause chronic infection
    • Severity: Usually self-limiting and resolves without specific treatment
    • Complications: Rarely causes liver failure or death

Hepatitis B Virus (HBV)

  • Etiology
    • Classification: A member of the Hepadnaviridae family
    • DNA Virus: HBV is a partially double-stranded DNA virus
    • Multiple Genotypes: There are multiple genotypes of HBV (A-J), which vary geographically
  • Epidemiology
    • Global Distribution: Found worldwide, with higher prevalence in certain regions, such as Asia and Africa
    • Chronic Infection: Approximately 257 million people worldwide are living with chronic HBV infection
    • Age Groups: Can affect all age groups, but chronic infection is more common in infants and young children
  • Transmission
    • Bloodborne: Spread through contact with infected blood or body fluids
    • Sexual Contact: A common route of transmission
    • Mother to Child: Can be transmitted from mother to child during childbirth (perinatal transmission)
    • Injection Drug Use: Sharing needles or syringes
    • Healthcare Settings: Unsafe injection practices, blood transfusions, and medical procedures
  • Disease States
    • Acute Hepatitis: Similar symptoms to HAV, including fever, fatigue, nausea, vomiting, abdominal pain, jaundice, dark urine, and pale stools
    • Chronic Hepatitis: Long-term infection that can lead to cirrhosis (scarring of the liver), liver failure, and hepatocellular carcinoma (liver cancer)
    • Asymptomatic Carriers: Some individuals with chronic HBV infection are asymptomatic carriers, meaning they do not have symptoms but can still transmit the virus
    • Severity: Chronic HBV infection can range from mild to severe
    • Complications: Cirrhosis, liver failure, hepatocellular carcinoma, and death

Hepatitis C Virus (HCV)

  • Etiology
    • Classification: A member of the Flaviviridae family
    • RNA Virus: HCV is a single-stranded RNA virus
    • Multiple Genotypes: There are multiple genotypes of HCV (1-7), which vary in their response to treatment
  • Epidemiology
    • Global Distribution: Found worldwide, with higher prevalence in certain regions
    • Chronic Infection: Approximately 71 million people worldwide are living with chronic HCV infection
    • Age Groups: Can affect all age groups, but chronic infection is more common in adults
  • Transmission
    • Bloodborne: Primarily spread through contact with infected blood
    • Injection Drug Use: Sharing needles or syringes is the most common route of transmission in many countries
    • Blood Transfusions: Before routine screening of blood products, blood transfusions were a significant source of transmission
    • Healthcare Settings: Unsafe injection practices and medical procedures
    • Sexual Contact: Less common than HBV, but can occur
    • Mother to Child: Can be transmitted from mother to child during childbirth (perinatal transmission), but less common than HBV
  • Disease States
    • Acute Hepatitis: Often asymptomatic or mild symptoms, such as fatigue and jaundice
    • Chronic Hepatitis: Long-term infection that can lead to cirrhosis, liver failure, and hepatocellular carcinoma
    • Asymptomatic Carriers: Many individuals with chronic HCV infection are asymptomatic for years or decades
    • Extrahepatic Manifestations: HCV can also cause other health problems, such as fatigue, joint pain, skin problems, and kidney disease
    • Severity: Chronic HCV infection can range from mild to severe
    • Complications: Cirrhosis, liver failure, hepatocellular carcinoma, and death

Diagnosis of Viral Hepatitis

  • Blood Tests: Used to detect viral antigens, antibodies, and nucleic acids
  • Serological Tests: Detect antibodies to HAV, HBV, and HCV
    • Anti-HAV IgM: Indicates acute HAV infection
    • HBsAg: Indicates current HBV infection
    • Anti-HCV: Indicates past or current HCV infection
  • Molecular Tests: Detect viral RNA or DNA
    • HAV RNA: Detects HAV RNA in serum or stool
    • HBV DNA: Detects HBV DNA in serum (viral load)
    • HCV RNA: Detects HCV RNA in serum (viral load)
  • Liver Function Tests (LFTs): Measure liver enzymes (e.g., ALT, AST) to assess liver damage
  • Liver Biopsy: May be necessary to assess the severity of liver damage and guide treatment decisions

Treatment of Viral Hepatitis

  • Hepatitis A (HAV)
    • Supportive Care: Rest, fluids, and pain relief
    • Vaccination: Effective vaccine available for prevention
  • Hepatitis B (HBV)
    • Antiviral Medications: Entecavir, tenofovir, and other antiviral drugs can suppress HBV replication and reduce the risk of liver damage
    • Interferon: Interferon alfa can be used to treat HBV infection, but is less commonly used than antiviral drugs
    • Vaccination: Effective vaccine available for prevention
  • Hepatitis C (HCV)
    • Direct-Acting Antivirals (DAAs): Highly effective medications that can cure HCV infection in most patients. Examples include sofosbuvir, ledipasvir, and velpatasvir
    • Treatment Duration: Typically 8-12 weeks
    • Sustained Virologic Response (SVR): Indicates that the virus has been eradicated from the body

Prevention of Viral Hepatitis

  • Vaccination: Effective vaccines are available for HAV and HBV
  • Hygiene Practices: Frequent handwashing, safe food handling, and proper sanitation
  • Safe Sex Practices: Using condoms can reduce the risk of HBV and HCV transmission
  • Safe Injection Practices: Avoiding sharing needles or syringes
  • Screening: Routine screening of blood products and high-risk individuals
  • Mother-to-Child Transmission Prevention: Antiviral medications and vaccination can prevent HBV transmission from mother to child

Key Terms

  • Etiology: The cause or origin of a disease or condition
  • Epidemiology: The study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems
  • Transmission: The way a disease is spread from one person or source to another
  • Hepatitis: Inflammation of the liver
  • Hepatitis A Virus (HAV): A virus that causes acute hepatitis, transmitted through the fecal-oral route
  • Hepatitis B Virus (HBV): A virus that can cause acute and chronic hepatitis, transmitted through blood and body fluids
  • Hepatitis C Virus (HCV): A virus that can cause acute and chronic hepatitis, transmitted primarily through blood
  • Jaundice: Yellowing of the skin and eyes
  • Cirrhosis: Scarring of the liver
  • Hepatocellular Carcinoma: Liver cancer
  • Serological Tests: Blood tests that detect viral antigens or antibodies
  • Molecular Tests: Tests that detect viral RNA or DNA
  • Viral Load: The quantity of virus present in a specific amount of a patient’s blood
  • Liver Function Tests (LFTs): Blood tests that measure liver enzymes
  • Direct-Acting Antivirals (DAAs): Medications that target specific steps in the HCV life cycle
  • Sustained Virologic Response (SVR): Eradication of the virus from the body
  • Fecal-Oral Route: Transmission of pathogens through contact with fecal matter and then ingestion
  • Bloodborne: Transmission of pathogens through contact with infected blood or body fluids
  • Asymptomatic Carrier: An individual who is infected with a virus but does not show symptoms